Brief: Genscript Biotech Says H1 Adjusted Net Profit Up 203.3% Y/Y
16/08/2026 11:39
BRIEF-Genscript Biotech Says H1 Adjusted Net Profit Up 203.3% Y/Y Aug 16 (Reuters) - Genscript Biotech Corp 1548.HK:
SAYS H1 ADJUSTED NET PROFIT UP 203.3% Y/Y, REVENUE UP 27.3%
Further company coverage: 1548.HK
(Reporting by Hong Kong newsroom)
((donny.kwok@thomsonreuters.com; +852 3462 7745;))
Recent news on Genscript Biotech
See all newsBrief: Genscript Launches Life Sciences Startup Pitchfest With Nvidia For Biotech Innovation
GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
GenScript Biotech hits near 5-year high on Eli Lilly collaboration
Brief: ProBio & Kun Tuo Announce Strategic Collaboration To Deliver Integrated CDMO-CRO Solutions
HK-listed GenScript Biotech drops on discounted share sale